Related Experiment Video
Updated: Aug 8, 2026

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
Interferon alpha and intracytoplasmic free calcium in hairy cell leukemia cells
1Unite 365 INSERM, Institut Curie, Paris, France.
Insights
Hairy cell leukemia (HCL) treatment with alpha-interferon (IFN-alpha) normalizes high cytoplasmic calcium levels in cancer cells. This suggests IFN-alpha may work by reducing calcium influx and CD20 phosphorylation.
Area of Science:
- Hematology
- Oncology
- Cell Biology
Background:
- Hairy cell leukemia (HCL) is a B-cell malignancy characterized by sensitivity to alpha-interferon (IFN-alpha) therapy.
- The precise mechanism by which IFN-alpha exerts its therapeutic effects in HCL remains largely unknown.
- Cytosolic calcium (Ca2+) deregulation is implicated in cell proliferation, differentiation, and apoptosis.
Purpose of the Study:
- To investigate the mechanism of action of IFN-alpha in HCL by identifying and characterizing cellular abnormalities.
- To determine if IFN-alpha treatment can rectify specific molecular abnormalities observed in HCL cells.
Main Methods:
- Identification of elevated free Ca2+ levels in the cytoplasm of HCL cells.
- Assessment of the effect of IFN-alpha treatment (in vitro and in vivo) on intracellular Ca2+ levels.
- Correlation of IFN-alpha's effect on Ca2+ with changes in CD20 phosphorylation status.
Main Results:
- HCL cells exhibit significantly high levels of cytoplasmic free Ca2+.
- IFN-alpha treatment effectively reduced these elevated Ca2+ levels in HCL cells.
- The reduction in Ca2+ by IFN-alpha correlated with the down-regulation of CD20 phosphorylation.
Conclusions:
- IFN-alpha therapy for HCL may function by reducing Ca2+ influx into leukemic cells.
- The observed effects of IFN-alpha on Ca2+ levels are linked to the modulation of CD20 phosphorylation.
- Understanding Ca2+ deregulation and IFN-alpha's action provides insights into HCL pathogenesis and treatment.
Abstract:
Hairy cell leukemia (HCL) is a B-cell tumor affecting the pre-plasma stage of B cell differentiation. One of the most striking characteristics of this disease is its remarkable responsiveness to alpha-interferon (IFN-alpha) therapy. Interferons constitute a heterologous family of multifunctional cytokines displaying anti-viral, anti-proliferative and immunoregulatory properties. These activities have been extensively studied in hairy cells, but the mechanism of action of IFN-alpha in hairy cell leukemia remains unknown. Our approach to investigate the mode action of IFN-alpha in HCL has been to identify abnormalities which occur in these tumor cells and then to ascertain whether these abnormalities can be rectified by IFN-alpha treatment. A high level of free Ca2+ in the cytoplasm of hairy cells was identified. Increases in cytosolic Ca2+ are believed to be a pivotal signal in regulating cell proliferation, cell differentiation and cell death. These high Ca2+ levels in hairy cells could be reduced upon treatment with IFN-alpha either in vitro or in vivo, probably acting by reducing Ca2+ influx into the leukemic cells. Moreover, the effect of IFN-alpha on [Ca2+]i seems to be correlated with down-regulation of CD20 phosphorylation, a B cell specific phosphoprotein involved in Ca2+ influx across the plasma membrane. The possible origins and implications of Ca2+ deregulation and the possible mechanisms or sites of action of IFN-alpha in tumor cells from HCL are explored in this review.
More Related Videos
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
07:15Single-Cell Characterization of Calcium Influx and HIV-1 Infection using a Multiparameter Optofluidic Platform
Published on: May 18, 2021